SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016236
Filing Date
2019-05-07
Accepted
2019-05-07 09:20:03
Documents
49
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krys-10q_20190331.htm 10-Q 1044793
2 EX-31.1 krys-ex311_8.htm EX-31.1 23526
3 EX-31.2 krys-ex312_7.htm EX-31.2 24127
4 EX-32.1 krys-ex321_6.htm EX-32.1 24066
  Complete submission text file 0001564590-19-016236.txt   3827023

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krys-20190331.xml EX-101.INS 723420
6 XBRL TAXONOMY EXTENSION SCHEMA krys-20190331.xsd EX-101.SCH 30904
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krys-20190331_cal.xml EX-101.CAL 35142
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krys-20190331_def.xml EX-101.DEF 85239
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20190331_lab.xml EX-101.LAB 252110
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20190331_pre.xml EX-101.PRE 196636
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 19801510
SIC: 2836 Biological Products, (No Diagnostic Substances)